Trellus Health (TRLS)

Sector:

Health Care

Index:

FTSE AIM All-Share

 3.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 11.00
  • 52 Week Low: 3.50
  • Currency: UK Pounds
  • Shares Issued: 161.51m
  • Volume: 36,627
  • Market Cap: £6.06m
  • Beta: 0.16

Trellus Health Overview

Trellus Health is commercialising the provision of digital chronic condition management solutions for employers and health plans that utilise the scientifically validated GRITT™ resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate™ to coordinate and deliver care remotely via telemedicine. The Company is initially focused on Inflammatory Bowel Diseases (IBD), which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis, but considers its approach to have potential utility and demand across many chronic conditions.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -48944.4% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 421.6 n/a
Pr/Book 0.3  
Latest F'cast
Revenue -28.0% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Trellus Health Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a (0.76) (1.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 0.03 (5.90) (0.04)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 0.02 (8.81) (0.05)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Trellus Health Company Announcements

Half-year Report 28-Sep-2023 07:00 RNS
Notice of Results 14-Sep-2023 07:00 RNS
Appointment of Chief Financial Officer 12-Sep-2023 07:00 RNS

Latest Trellus Health Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Trellus Health Market Data

Currency UK Pounds
Share Price 3.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 11.00
52 Week Low 3.50
Volume 36,627
Shares Issued 161.51m
Market Cap £6.06m
Beta 0.16

Trellus Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.18% above the market average47.18% above the market average47.18% above the market average47.18% above the market average47.18% above the market average
37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average
Price Trend
91.62% below the market average91.62% below the market average91.62% below the market average91.62% below the market average91.62% below the market average
61.11% below the sector average61.11% below the sector average61.11% below the sector average61.11% below the sector average61.11% below the sector average
Income Not Available
Growth
24.56% below the market average24.56% below the market average24.56% below the market average24.56% below the market average24.56% below the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average

Trellus Health Dividends

No dividends found

Trades for 08-Dec-2023

Time Volume / Share Price
13:39 36,627 @ 3.50p

Trellus Health Key Personnel

CEO Marla Dubinsky

Top of Page